Erez Chimovits - Net Worth and Insider Trading

Erez Chimovits Net Worth

The estimated net worth of Erez Chimovits is at least $123 Million dollars as of 2024-11-29. Erez Chimovits is the Director, 10% Owner of Upstream Bio Inc and owns about 5,693,589 shares of Upstream Bio Inc (UPB) stock worth over $121 Million. Erez Chimovits is the Director of Eledon Pharmaceuticals Inc and owns about 176,852 shares of Eledon Pharmaceuticals Inc (ELDN) stock worth over $753,390. Erez Chimovits is also the Director, 10% Owner of LogicBio Therapeutics Inc and owns about 296,296 shares of LogicBio Therapeutics Inc (LOGC) stock worth over $613,333. Besides these, Erez Chimovits also holds BiomX Inc (PHGE) , Logic Devices Inc (LOGC) . Details can be seen in Erez Chimovits's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Erez Chimovits has not made any transactions after 2024-10-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Erez Chimovits

To

Erez Chimovits Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Erez Chimovits owns 5 companies in total, including LogicBio Therapeutics Inc (LOGC) , BiomX Inc (PHGE.U) , and Eledon Pharmaceuticals Inc (ELDN) among others .

Click here to see the complete history of Erez Chimovits’s form 4 insider trades.

Insider Ownership Summary of Erez Chimovits

Ticker Comapny Transaction Date Type of Owner
LOGC LogicBio Therapeutics Inc 2020-10-01 director
PHGE.U BiomX Inc 2020-03-25 director & 10 percent owner
ELDN Eledon Pharmaceuticals Inc 2019-05-02 director
LIMIT LIMIT 2020-09-15 director
LIMIT LIMIT 2019-12-19 director & 10 percent owner

Erez Chimovits Latest Holdings Summary

Erez Chimovits currently owns a total of 5 stocks. Among these stocks, Erez Chimovits owns 5,693,589 shares of Upstream Bio Inc (UPB) as of October 15, 2024, with a value of $121 Million and a weighting of 98.77%. Erez Chimovits owns 176,852 shares of Eledon Pharmaceuticals Inc (ELDN) as of May 2, 2019, with a value of $753,390 and a weighting of 0.61%. Erez Chimovits also owns 296,296 shares of LogicBio Therapeutics Inc (LOGC) as of October 1, 2020, with a value of $613,333 and a weighting of 0.5%. The other 2 stocks BiomX Inc (PHGE) , Logic Devices Inc (LOGC) have a combined weighting of 0.11% among all his current holdings.

Latest Holdings of Erez Chimovits

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
UPB Upstream Bio Inc 2024-10-15 5,693,589 21.26 121,045,702
ELDN Eledon Pharmaceuticals Inc 2019-05-02 176,852 4.26 753,390
LOGC LogicBio Therapeutics Inc 2020-10-01 296,296 2.07 613,333
PHGE BiomX Inc 2019-12-19 231,349 0.60 139,087
LOGC Logic Devices Inc 2018-10-23 3,487,760 0.00 0

Holding Weightings of Erez Chimovits


Erez Chimovits Form 4 Trading Tracker

According to the SEC Form 4 filings, Erez Chimovits has made a total of 1 transactions in Upstream Bio Inc (UPB) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Upstream Bio Inc is the acquisition of 825,000 shares on October 15, 2024, which cost Erez Chimovits around $14 Million.

According to the SEC Form 4 filings, Erez Chimovits has made a total of 0 transactions in Eledon Pharmaceuticals Inc (ELDN) over the past 5 years. The most-recent trade in Eledon Pharmaceuticals Inc is the acquisition of 35,901 shares on May 2, 2019, which cost Erez Chimovits around $2 Million.

According to the SEC Form 4 filings, Erez Chimovits has made a total of 1 transactions in LogicBio Therapeutics Inc (LOGC) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in LogicBio Therapeutics Inc is the acquisition of 1,481,482 shares on October 1, 2020, which cost Erez Chimovits around $9 Million.

More details on Erez Chimovits's insider transactions can be found in the Insider Trading History of Erez Chimovits table.

Insider Trading History of Erez Chimovits

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Erez Chimovits Trading Performance

GuruFocus tracks the stock performance after each of Erez Chimovits's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Erez Chimovits is -11.5%. GuruFocus also compares Erez Chimovits's trading performance to market benchmark return within the same time period. The performance of stocks bought by Erez Chimovits within 3 months outperforms 3 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Erez Chimovits's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Erez Chimovits

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 5 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -6.4 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -7.11 LIMIT LIMIT LIMIT LIMIT LIMIT

Erez Chimovits Ownership Network

Ownership Network List of Erez Chimovits

No Data

Ownership Network Relation of Erez Chimovits

Insider Network Chart

Erez Chimovits Owned Company Details

What does LogicBio Therapeutics Inc do?

Who are the key executives at LogicBio Therapeutics Inc?

Erez Chimovits is the director of LogicBio Therapeutics Inc. Other key executives at LogicBio Therapeutics Inc include Chief Scientific Officer Mariana Nacht , Chief Medical Officer Daniel Gruskin , and Interim CFO Joshua Blacher .

LogicBio Therapeutics Inc (LOGC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of LogicBio Therapeutics Inc (LOGC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of LogicBio Therapeutics Inc (LOGC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

LogicBio Therapeutics Inc (LOGC)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

LogicBio Therapeutics Inc Insider Transactions

No Available Data

Erez Chimovits Mailing Address

Above is the net worth, insider trading, and ownership report for Erez Chimovits. You might contact Erez Chimovits via mailing address: P.o. Box 4023, Herzliya Pituach L3 4614001.

Discussions on Erez Chimovits

No discussions yet.